Last reviewed · How we verify
NCT06122519
Characteristics of Eye Diseases in Children and Adolescents With Autism Spectrum Disorders and the Effect of Corresponding Treatment on the Quality of Life of Children and Adolescents With Autism and Their Caregivers
trial in Autism Spectrum Disorder in 1,000 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | Tianjin Eye Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 April 2023 |
| Primary completion | 1 April 2024 |
| Estimated completion | 1 April 2024 |
| Sites | 1 location across China |
Conditions studied
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
- Visual Function — all drugs for Visual Function →
Sponsor
Tianjin Eye Hospital
Who can join
Adults 2 to 18, any sex, with Autism Spectrum Disorder or Visual Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study mainly investigated the incidence of eye diseases in children with autism spectrum disorder(ASD) in Tianjin area, and analyzed related risk factors, so as to raise attention to eye diseases in children with ASD. To evaluate the impact of ophthalmic treatment on the quality of life of children with autism and their primary caregivers.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Refractive Errors and Ocular Biometric Parameters in Children with Autism Spectrum Disorder in Handan: A Cross-Sectional Study.
Cheng Y, Wang J, Liu M, Guo D, et al · · 2026 · PMID 41924538 · DOI 10.2147/ijgm.s572336
Verify or expand the search:
- PubMed search for NCT06122519
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Autism Spectrum Disorder
Currently open trials in the same condition.
- NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
- NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
- NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting
Other Tianjin Eye Hospital trials
Trials by the same sponsor.
- NCT07518316 — Factors Influencing Subjective Visual Quality in Human Eyes · NA · not yet recruiting
- NCT06993077 — Impact of Ultraviolet Radiation and Environmental Factors on Human Ocular Biomechanics · active not recruiting
- NCT06694051 — Application of Phototherapeutic Keratectomy Mode to Mark the Axis of Astigmatism · NA · recruiting
- NCT07244276 — Comparison of Compressed Continuous Suture and Conventional Suture in Pterygium Surgery · NA · recruiting
- NCT07171710 — Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögr · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06122519 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin Eye Hospital
- Last refreshed: 8 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06122519.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing